Osteologix musculoskeletal news

Osteologix will voluntarily deregister its common stock and suspend reporting obligations, effective Jan. 1, 2011, to save cash. The company also will close its U.S. office and consolidate operations to its Dublin, Ireland, office. At Sept. 30, Osteologix had $4.1 million in cash and nine-month operating gain of $836,000. ...